Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and inter...
The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%
LIFERIVER released its performance for the first three quarters, with a net loss attributable to the parent company of 29.38 million yuan
LIFERIVER: Plans to repurchase shares for 60 million to 120 million yuan
LIFERIVER: Monkeypox virus nucleic acid testing kit (fluorescent PCR method) included in WHO emergency use list
LIFERIVER: Has established a product line for the detection of mosquito-borne infectious diseases, including the Chikungunya virus
Monkeypox concept stocks surged, KHB hit the limit up